Retension Pharmaceuticals
Retension Pharmaceuticals is developing RTN-001, a differentiated, tissue-targeted PDE5 inhibitor that has been optimized for the treatment of uncontrolled hypertension. RTN-001 has been evaluated in over 265 subjects across 9 clinical…
This is the record ChatGPT, Claude and Google read about Retension Pharmaceuticals. Claiming it controls the source; answers update as assistants re-crawl.
- Founded
- 2023
- Headcount
- 2
- Open roles
- 0
- Last raised
- Series B
Where they work
Retension Pharmaceuticals offices
- Falls Church, VA1104 West Broad Street #1029
Capital raised
Roles at Retension Pharmaceuticals
Employbl doesn’t track Retension Pharmaceuticals’s job board yet, so there’s nothing to show here — they may still be hiring. You can also search all jobs →
Hiring team? Claim the profile to keep roles and the careers link accurate
Founders & key people
Companies like Retension Pharmaceuticals
Picked from companies in the same industries as Retension Pharmaceuticals, ranked by funding-stage adjacency and hiring activity.
Allara
Manhattan Park, NY · Series B
Allara offers a medical provider and a registered dietitian for polycystic ovary syndrome. They provides holistic care, diagnostic testing,…
WelbeHealth
Menlo Park, CA · Series C
Welbe Health, LLC provides health care services. The Company offers seniors care services. Welbe Health serves customers in the State of…
